Microarchitecture and Nanomechanical Properties of Trabecular Bone After Strontium Administration in Osteoporotic Goats

Abstract

Strontium (Sr) ralenate is a new agent used for the prevention and treatment of osteoporosis. As a bone-seeking element, 98% of Sr is deposited in the bone and teeth after oral ingestion. However, the effect of Sr treatment on bone microarchitecture and bone nanomechanical properties remains unclear. In this study, 18 osteoporotic goats were divided into four groups according to the treatment regimen: control, calcium alone (Ca), calcium and Sr at 24 mg/kg (Ca + 24Sr), and calcium and Sr at 40 mg/kg (Ca + 40Sr). The effects of Sr administration on bone microarchitecture and nanomechanical properties of trabecular bones were analyzed with micro-CT and nanoindentation test, respectively. Serum Sr levels increased six- and tenfold in the Ca + 24Sr and Ca + 40Sr groups, respectively. Similarly, Sr in the bone increased four- and sixfold in these two groups. Sr administration significantly increased trabecular bone volume fraction, trabecular thickness, and double-labeled new bone area. Sr administration, however, did not significantly change the nanomechanical properties of trabecular bone (elastic modulus and hardness). The data suggested that Sr administration increased trabecular bone volume and improved the microarchitecture while maintaining the intrinsic tissue properties in the osteoporotic goat model.

Introduction

Osteoporosis is characterized by impaired bone quality which leads to decreased bone strength and increased susceptibility to fractures. Strontium (Sr)-containing compounds have been reported to exert anabolic effects on the skeleton when orally administered to animals [1, 2] and postmenopausal women [3–5]. Treatment with these agents increases bone mineral content and density, particularly at skeletal sites that are rich in trabecular bone, such as the lumbar spine [2, 3, 6, 7]. In humans, studies on the mechanical properties of bone responsible for the anabolic action of Sr is mainly achieved by evaluation of fracture risks [3–5]. Human studies are limited by the difficulty in obtaining consistent specimens suitable for rigorous examination. So far, information on the microarchitecture and nanomechanical properties in response to Sr treatment in large osteoporosis animal models is lacking.

Nanoindentation has been proven to be a powerful tool for the measurement of local mechanical properties and is a fairly mature technique for measurements in biological tissues of the intrinsic material mechanical properties. This method circumvents common limitations that arise when applying large-scale mechanical testing techniques to biological tissues [8–10]. With the help of nanoindentation, measurement of localized changes due to enhanced or inhibited bone mineralization and remodeling becomes feasible. In recent years, micro-computerized tomography (μCT) has been used to measure 3D bone structure of animals due to its relative ease in sample preparation, its noninvasive nature, and the high spatial resolution as compared with conventional histology [11]. Studies have demonstrated that μCT analysis of change patterns in 3D bone parameters may serve as a valuable tool for the evaluation of both anti-resorptive and anabolic agents in ovariectomized (OVX) animals [12].

Low dosage of Sr was employed in this study as Sr at high dosage may have deleterious effects on the bone [13–16]. For instance, Sr at high dosage may induce rickets, a disease characterized by the softening of bone, due simply to high levels of this element in soil, together with the possible contributions from the lack of sunshine and Ca dietary deficiency [17, 18]. Since the main target populations for Sr treatment are postmenopausal osteoporotic women who are also susceptible to reduced renal function, the risk for osteomalacia should be considered. Ca and P supplements are added into the treatment regimen of Sr as the efficient absorption of these two elements plays an essential role in any increase in bone mass by forming osteoid and hydroxyapatite, which compose the bulk of bones [19, 20].

In a previous study, we reported that Sr–Ca co-administration stimulated new bone formation as assessed by histomorphometry and molecular analysis of gene expressions [21]. In this work, we aimed to evaluate bone microarchitecture and nanomechanics at the lumbar spine of skeletally mature OVX goats after Sr–Ca co-administration for 16 weeks. The trabecular microarchitectural parameters were quantified from μCT, while the nanomechanical properties of single trabecula were determined by nanoindentation tests.

Materials and Methods

Animals

Eighteen goats with a mean age of 6.9 years (range, 6–8 years) were ovariectomized by surgical procedures approved by the local ethics committee to induce osteoporosis 1 year before the evaluation was initiated. The mean weight of the goats was 37.5 kg (range, 35–43 kg). The animals were then randomly assigned into four groups: (1) the control group (n = 3), (2) the Ca group (n = 5), (3) the Ca + 24Sr group (n = 5), and (4) the Ca + 40Sr group (n = 5). All goats were fed with Rumilab Diet 5508 (Purina Mills, Richmond, IN, USA). Animals in the control group were fed with the above feed with low calcium. For animals in the treated groups, tricalcium phosphate (TCP) and Sr-fortified tricalcium phosphate (Sr-TCP) powder, synthesized by partially substituting Ca in TCP with Sr, were supplied in the feed and administered daily for 16 weeks. For animals in the Ca alone group, Ca phosphate was supplied in the feed at the elemental dosage of 100 mg kg⁻¹ day⁻¹. In addition to Ca supplementation, Sr phosphate was supplied at 24 and 40 mg kg⁻¹ day⁻¹ to the Ca + 24Sr and Ca + 40Sr groups, respectively. The detailed treatment dosages are listed in Table 1. At 14 and 3 days before killing, each animal was injected with 20 mg/kg tetracycline (Terramycin, Pfizer) to obtain a double fluorescent label at the site of active bone formation. All animals were killed at week 16 from the onset of treatment.

Table 1.

Groups and dosages of the experimental design

Groups	Elemental dosages		No. of goats
	Ca (mg/kg/day)	Sr (mg/kg/day)
Control	0	0	3
Ca	100	0	5
Ca + 24Sr	100	24	5
Ca + 40Sr	100	40	5

Serum Biochemistry

Blood samples were collected for Sr and Ca serum analysis by aortic puncture right before killing. The serum samples were prepared by acid digestion and the concentrations determined by applying inductively coupled plasma–atomic emission spectrometry (ICP-AES; iCAP 6300, Thermo Jarrell Ash Co., USA).

Bone Mineral Content

The bone mineral content was measured in bone blocks taken from the lumbar vertebrae (L2). The blocks were washed with distilled water before dehydrated at 100°C for 24 h in an oven and calcinated at 600°C for 20 h. After calcination, the bone ashes were then dissolved in 6 N HCl. The Ca and Sr contents of the ashes were then determined by ICP-AES (iCAP 6300, Thermo Jarrell Ash Co.).

Bone Specimen Preparation

Lumbar vertebrae (L1–L4) were harvested from the fresh goat cadaver and freed of soft tissues. L3 was fixed in Millonig’s phosphate-buffered 10% formalin, pH 7.4, at 4°C. After 24 h, transverse sections (1-cm thickness) were prepared from the middle of each L3 vertebral body and dehydrated successively in 70%, 95%, and 100% ethanol before cleaning in xylene. These undecalcified specimens were then embedded in poly(methylmethacrylate) (PMMA).

Specimen of L3 with PMMA embedding was processed with a high-speed, water-cooled diamond saw (EXAKT 300 CP Band System, Norderstedt, Germany) to give transverse sections of two different thicknesses: 3 mm and 40 μm. After being used for μCT test, the 3-mm-thick sections were polished by sand paper with increasing fineness from 240 to 1,200 grit and then further polished on a micro-cloth with 6-, 1-, and 0.05-μm alumina suspension for μCT and the nanoindentation test. The 40-μm-thick sections were polished (EXAKT 400 CS Micro Grinding System, Norderstedt, Germany) and mounted for visualization by fluorescent microscopy (Nikon H600L Microscope System, Japan).

New Bone Area Measurement

To measure the new bone formation, the new bone area between the tetracycline labels in cancellous bone was determined. On the unstained 40-μm-thick sections, double-labeled bone areas (dL.Ar_i) were obtained and normalized to trabecula area (in percent, dL.Ar/Tb.Ar) under fluorescent microscopy (as shown in Fig. 1) on six representative fields per bone sample. The representative tissue percentage occupied by the double-labeled bone (dL.Ar/Tb.Ar) were computer-generated using the equation below:

\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\rm dL} .Ar/{\rm Tb} .Ar = \frac{{\sum\limits_{{i = 1}}^6 {{\rm dL} .A{r_i}} }}{{\sum\limits_{{i = 1}}^6 {{\rm Tb} .A{r_i}} }} $$\end{document}

Fig. 1.

Tetracycline double-labeled areas under fluorescent microscopy. Measurements of double-labeled surface area (dL.Ar_i) of selected scope and the area of trabecular bone (B.Ar_i) were performed on six representative fields for each sample. The result is given by percentage of double-labeled area to bone area (dL.Ar/B.Ar)

The measurement was 2D, confined to the spongiosa, and made using a ×40 objective lens. Image analyses were automatically performed with a program of Image Pro Plus 5.0 (Media Cybernetics, Inc. MD, USA).

Micro-CT Scanning

PMMA-embedded lumbar vertebrae (L3) were cut to give 3-mm midshaft cross-sections for 3D data and image acquisition using a desktop μCT system (μCT-40; Scanco Medical, Bassersdorf, Switzerland). Micro-CT scans were performed on the entire 3-mm specimen to give 100 successive 30-μm slices. Scanning was performed with the following parameters: 21-μm isotropic voxel size, 55-keV voltage, 109-mA current, 200-ms integration time, and 4,000 projections. Three-dimensional information was obtained by stacking the measured slices on top of each other. After digital removal of the surrounding cortical bone, the entire spongiosa was used for subsequent morphometric analysis. A representative 3D visualization of a complete measurement is shown in Fig. 2. Bone volume fraction (bone volume/total volume (BV/TV)), trabecular thickness (Tb.Th), number (Tb.N), and separation (Tb.Sp) were also evaluated. The connectivity density (Conn.D) was calculated using the Euler method [22].

Fig. 2.

Representative Micro-CT 3D image of cross-sectional bone from the goat lumbar vertebral body (L3). The microarchitectures of the lumbar spine of goats in the four different groups are shown above

Nanoindentation Test and Data Analysis

After assessment with the μCT test, the 3-mm-thick sections were polished by sandpaper with increasing fineness (from 240 to 1,200 grit) and then further polished on a micro-cloth with 6-, 1-, and 0.05-μm alumina suspension for the nanoindentation test. The test was performed using a nanoindenter equipped with a Beckovich tip (CSM Instruments SA, Switzerland). For ease of comparison, a typical load-hold scheme, with a peak load of 4 mN, loading rate 8 mN/min, holding time 60 s, and unloading rate 10 mN/min, was used for all the nanoindentation tests in this study. Five different regions were selected for the nanoindentation tests to reduce random errors, as shown in Fig. 3a. In each region, five indents were made to calculate the elastic modulus and hardness of nanoindentation (Fig. 3b, c). With the nanoindentation technique, the most commonly used method for data analysis is the Oliver–Pharr method [23], which assumes that the tip–sample contact is purely elastic. Here, we employed a method developed by Ngan et al. [24, 25] that corrected for the viscoelastic effects during nanoindentation measurements.

Fig. 3.

Nanoindentation test performed on single trabecula of lumbar vertebra. a Nanoindentation test was performed at five different regions. b Indents were performed on the junction of trabeculae to prevent potential artifacts caused by intrinsic bone defects. For each region, six indents were performed, the larger one for marking (b) and the other five for data collection (c)

Statistical Analysis

All data were expressed as the mean ± SD. The analysis was performed with one-way analysis of variance. A Student–Neuman–Keuls post hoc test was conducted on the pooled data to determine the differences between the groups at a significance level of p < 0.05.

Results

Serum Biochemistry

The Sr serum concentrations before and after treatments are shown in Fig. 4. No significant difference was observed between the control and treated groups prior to treatment. The mean serum Sr concentrations in the Ca group (2.44 ± 0.31 × 10⁻³ mmol/l) and control group (3.34 ± 0.12 × 10⁻³ mmol/l) were comparable. In contrast, the mean Sr concentration in the Ca + 24Sr and Ca + 40Sr groups increased considerably to 19.38 ± 3.46 × 10⁻³ and 35.28 ± 7.88 × 10⁻³ mmol/l, respectively.

Fig. 4.

Strontium serum concentrations pre- and post-treatments. No significant difference was observed between the control and treated groups prior to treatment. Ca alone treatment decreased Sr level marginally; in contrast, Sr concentrations increased considerably with Ca–Sr co-administration

Bone Mineral Content

As shown in Fig. 5, the Ca group (296 ± 39 mg/kg) had slightly decreased Sr concentrations in the lumbar vertebrae compared with the control group (331 ± 87 mg/kg). The lumbar vertebrae Sr levels were increased to 1,133 ± 341 and 1,834 ± 417 mg/kg in the Ca + 24Sr and Ca + 40Sr groups, respectively.

Fig. 5.

Strontium concentration in lumbar vertebra. Sr concentration decreased slightly with Ca alone treatment; however, Ca–Sr co-administration increased Sr levels significantly in both femur and lumbar vertebra

New Bone Area Measurement

In order to observe the anabolic effects of Sr, tetracycline double-labeled areas (dL.Ar/B.Ar) were measured. In the control and Ca treatment groups, the dL.Ar/B.Ar were 3.49 ± 1.01% and 3.61 ± 0.98%, respectively, and no significant difference was observed. However, the dL.Ar/B.Ar was significantly increased by 16.90% (p = 0.043) and 32.33% (p = 0.037) in the Ca + 24Sr and Ca + 40Sr groups, respectively.

Micro-CT Parameters of Lumbar Vertebral Body

Table 2 summarizes the effects of all treatments on 3D bone microarchitecture parameters. Trabecular bone volume fraction (bone volume/tissue volume, BV/TV) was significantly greater in the Ca + 24Sr group compared with both the control and Ca groups (+12.22% and +9.78%, p = 0.010 and 0.0432, respectively). BV/TV was also significantly greater in the Ca + 40Sr group compared with both the control and Ca groups (+22.78% and +20.11%, p = 0.003 and 0.012, respectively). Tb.Th was significantly greater in both Ca + 24Sr and Ca + 40Sr groups compared with the control group (+21.84% and +32.76%, p = 0.038 and 0.015, respectively). Meanwhile, Tb.Th was significantly greater in both Ca + 24Sr and Ca + 40Sr groups compared with the Ca group (+13.98% and +24.19%, p = 0.032 and 0.028, respectively). The decrease in Tb.N was accompanied with an increase in Tb.Sp in response to treatment with Ca alone. In contrast, in response to Sr–Ca treatment, Tb.N increased while Tb.Sp decreased. The Conn.D was increased slightly in Ca alone, while it was significantly greater in the Ca + 24Sr and Ca + 40Sr groups (35.46% and 28.22%, p = 0.029 and 0.034, respectively) compared with the control group.

Table 2.

Microarchitecture parameters of lumbar vertebral body of goats in control and experimental groups

Parameter	Groups
	Control	Ca	Ca + 24Sr	Ca + 40Sr
BV/TV	0.180 ± 0.006	0.184 ± 0.009	0.202 ± 0.013*,**	0.221 ± 0.017*,**
Tb.Th (mm)	0.174 ± 0.016	0.186 ± 0.020	0.212 ± 0.025*,**	0.231 ± 0.031*,**
Tb.Sp (mm)	0.474 ± 0.062	0.519 ± 0.135	0.435 ± 0.048	0.432 ± 0.045
Tb.N (1/mm)	2.337 ± 0.593	2.123 ± 0.656	2.559 ± 0.432	2.618 ± 0.530
Conn.D (1/mm3)	3.154 ± 0.791	3.419 ± 0.862	3.789 ± 1.010*	4.003 ± 1.208*

*p < 0.05 (vs. control group); **p < 0.05 (vs. Ca group)

Nanoindentation of Single Trabecula

The elastic modulus (E) and hardness (H) of the single trabecula is shown in Table 3. The mean modulus of these four groups was comparable and no significant difference was observed. Although we observed a tendency for both Ca alone and Ca combined with Sr to increase the elastic modulus to hardness ratio (E/H), this effect was not found to be statistically significant. The E/H increased by 0.86% (p = 0.746) in the Ca-alone treatment group. In the Ca + 24Sr and Ca + 40Sr groups, the E/H increased by 7.64% (p = 0.378) and 6.72% (p = 0.122), respectively.

Table 3.

Elastic modulus (E) and hardness (H) of single trabecula

Group	Elastic modulus, E (GPa)	Hardness, H (MPa)	E/H
Control	14.025 ± 0.017	685.800 ± 37.937	20.790 ± 0.707
Ca	14.052 ± 1.102	670.146 ± 62.170	20.970 ± 0.461
Ca + 24Sr	14.017 ± 0.297	639.959 ± 63.869	22.378 ± 2.100
Ca + 40Sr	13.542 ± 0.665	642.025 ± 28.620	22.187 ± 0.720

Discussion

The OVX goat is an acceptable animal model of osteoporosis that allows a detailed study of the effects of therapies at skeletal sites relevant to the treatment of osteoporosis [26, 27]. In a previous study on OVX goats, we showed that Sr–Ca co-administration significantly increased mineral apposition rate and the osteoblast-related gene expression (Runx2), demonstrating the anabolic effect of Sr–Ca compound in the OVX goat model. However, it remains unknown whether the Sr-mediated anabolic effect leads to better trabecular bone microarchitecture and intrinsic bone tissue properties. Our data presented here showed that Sr–Ca co-administration significantly improved trabecular bone mass and microarchitecture while not altering the intrinsic bone tissue properties of trabecular bone.

The dosage of Sr treatment varied in a wide range in the animal studies. In a recent study on OVX rats, Sr at the dose of 25 mg kg⁻¹ day⁻¹ failed to exert anabolic effect on the trabecular bone [28]. The effective dose of Sr treatment in the animals ranged from 100 to 1,024 mg kg⁻¹ day⁻¹ [29–32]. The Sr dosages used in the present study were lower than that in the previous animal studies [29–32], but improved both static and dynamic bone histomorphometry parameters as assessed by micro-CT and bone histomorphometry, respectively. The higher bone volume is mainly due to higher trabecular thickness, as there was no significant change for trabecular number, suggesting that the main anabolic effect of Sr is to thicken the existing trabeculae instead of restoring trabecular number. To validate the anabolic effect of Sr on bone at the tissue level, we evaluated the dynamic bone formation parameter using double fluorescence labeling. The dynamic bone formation parameter such as the double-labeled new bone area was significantly higher in the Sr–Ca compound group compared with the Ca or control groups. These data from the micro-CT and bone histomorphometry reflect that the activity of osteoblasts/progenitors in bones has increased after Sr–Ca compound treatment.

Calcium supplementation alone did not change the serum or bone Ca levels, but did result in a marginally decreased serum and bone Sr concentrations. This may be due to the competitive effect between Sr and Ca which share similar physical and chemical properties. Furthermore, the bone mineral content assay indicated that Sr was taken up by the bone matrix in cancellous (lumbar vertebrae) bone in a dose-dependent manner. Even though Sr content significantly increased, the level of Ca was not considerably changed since the amount of Ca was much higher than the trace element Sr.

Bone strength is determined not only by bone geometry, cortical bone thickness, porosity, and trabecular bone microarchitecture but also by the intrinsic bone tissue property. The effect of Sr treatment on bone mineral density, volume, and microarchitecture has been intensively investigated in a number of studies. Very little information on the effect of Sr on intrinsic bone tissue quality is available [1]. By the nanoindentation test, we demonstrated that there were no significant changes for both elastic modulus and hardness in trabecular bone in Sr treatment and Ca or control groups. These results are consistent with the recent report that showed no significant difference for elastic modulus between placebo and Sr ranelate group in postmenopausal women [33]. The condition for the samples (dry or wet) plays an essential role on the determination of effect of Sr treatment on elastic modulus or hardness. As in another study, significant effects of Sr treatment on the elastic modulus, hardness, and dissipated energy are only observed in the vertebrae samples in physiological (hydrated) but not in dry conditions [1]. The reason for the failure to observe the obvious effect of Sr treatment on intrinsic tissue quality at dry conditions remains unknown. One of the possible reasons is that in the bone mineral phase, Sr is mainly located in the hydrated layer and could potentially structurally modify the bone matrix in relation to the hydration state of the bony tissue.

In this study, hardness in all treatment groups was lower compared with the control group, and the differences were not statistically significant. Indentation hardness of the bone depends heavily on the degree of bone mineralization [34]. Under the influence of the anabolic effect of Sr, the slight decrease in bone hardness may result from the enhanced formation of a less mineralized new bone. E/H is useful in the evaluation of the overall deformation characteristics during indentation and is proportional to the fracture toughness of the bone [35]. Higher E/H values correspond to a more ductile material, while lower E/H values generally indicate a more brittle material. Upon treatment with Sr, a considerably higher E/H ratio, without statistical significance, was observed.

The result of a large animal model will show more clinical relevance than that of rodents, but there are still some limitations in the current study, such as the relatively small sample size compared with small animal studies. Increasing the sample size in each group may provide more valuable statistical representation for the data. The hardness and modulus of a single trabecula were determined in dehydrated sample, which was different from physiological conditions. Obviously, more work has to be conducted on fresh samples to guarantee the elucidation of the Sr treatment on the nanomechanical properties of bone.

In conclusion, our findings showed that Sr treatment stimulated new bone formation and also improved bone microstructure in osteoporotic goats as measured by μCT. Sr treatment significantly increased trabecular bone volume primarily by increasing trabecular thickness, but the nanomechanical properties of a single trabecula were not altered. The results suggested that the reduced osteoporotic fracture risk was mainly due to the improvement in bone microarchitecture instead of the intrinsic tissue properties of a single bone unit.